Microglia and Cholesterol Handling: Implications for Alzheimer's Disease

Overview

Journal Biomedicines

Specialty Biomedical Engineering

Date 2022 Dec 23

PMID 36551857

Authors

Oscar M Munoz Herrera

Angela M Zivkovic

Affiliations

Soon will be listed here.

Abstract

Cholesterol is essential for brain function and structure, however altered cholesterol metabolism and transport are hallmarks of multiple neurodegenerative conditions, including Alzheimer's disease (AD). The well-established link between apolipoprotein E (APOE) genotype and increased AD risk highlights the importance of cholesterol and lipid transport in AD etiology. Whereas more is known about the regulation and dysregulation of cholesterol metabolism and transport in neurons and astrocytes, less is known about how microglia, the immune cells of the brain, handle cholesterol, and the subsequent implications for the ability of microglia to perform their essential functions. Evidence is emerging that a high-cholesterol environment, particularly in the context of defects in the ability to transport cholesterol (e.g., expression of the high-risk APOE4 isoform), can lead to chronic activation, increased inflammatory signaling, and reduced phagocytic capacity, which have been associated with AD pathology. In this narrative review we describe how cholesterol regulates microglia phenotype and function, and discuss what is known about the effects of statins on microglia, as well as highlighting areas of future research to advance knowledge that can lead to the development of novel therapies for the prevention and treatment of AD.

Citing Articles

Mouse-to-human modeling of microglia single-nuclei transcriptomics identifies immune signaling pathways and potential therapeutic candidates associated with Alzheimer's disease.

Bergendorf A, Park J, Ball B, Brubaker D bioRxiv. 2025; .

PMID: 39975195 PMC: 11839086. DOI: 10.1101/2025.02.07.637100.

Mitochondria-Associated Endoplasmic Reticulum Membranes in Microglia: One Contact Site to Rule Them all.

Navarro E, Montesinos J Contact (Thousand Oaks). 2025; 8:25152564241312807.

PMID: 39881949 PMC: 11775980. DOI: 10.1177/25152564241312807.

The Aβ:Aβ ratio modulates aggregation in beta-amyloid oligomers and drives metabolic changes and cellular dysfunction.

Haessler A, Gier S, Jung N, Windbergs M Front Cell Neurosci. 2024; 18:1516093.

PMID: 39717390 PMC: 11664223. DOI: 10.3389/fncel.2024.1516093.

Inhibiting the Cholesterol Storage Enzyme ACAT1/SOAT1 in Myelin Debris-Treated Microglial Cell Lines Activates the Gene Expression of Cholesterol Efflux Transporter ABCA1.

Huynh T, Havrda M, Zanazzi G, Chang C, Chang T Biomolecules. 2024; 14(10).

PMID: 39456234 PMC: 11505751. DOI: 10.3390/biom14101301.

HIV-TAT dysregulates microglial lipid metabolism through SREBP2/miR-124 axis: Implication of lipid droplet accumulation microglia in NeuroHIV.

Cheng Y, Jung J, Guo L, Shuboni-Mulligan D, Chen J, Hu W Brain Behav Immun. 2024; 123:108-122.

PMID: 39260763 PMC: 11624073. DOI: 10.1016/j.bbi.2024.09.011.

References

Fitzgerald M, Mendez A, Moore K, Andersson L, Panjeton H, Freeman M . ATP-binding cassette transporter A1 contains an NH2-terminal signal anchor sequence that translocates the protein's first hydrophilic domain to the exoplasmic space. J Biol Chem. 2001; 276(18):15137-45. DOI: 10.1074/jbc.m100474200. View

Yongjun Y, Shuyun H, Lei C, Xiangrong C, Zhilin Y, Yiquan K . Atorvastatin suppresses glioma invasion and migration by reducing microglial MT1-MMP expression. J Neuroimmunol. 2013; 260(1-2):1-8. DOI: 10.1016/j.jneuroim.2013.04.020. View

Bellenguez C, Kucukali F, Jansen I, Kleineidam L, Moreno-Grau S, Amin N . New insights into the genetic etiology of Alzheimer's disease and related dementias. Nat Genet. 2022; 54(4):412-436. PMC: 9005347. DOI: 10.1038/s41588-022-01024-z. View

Trompier D, Vejux A, Zarrouk A, Gondcaille C, Geillon F, Nury T . Brain peroxisomes. Biochimie. 2013; 98:102-10. DOI: 10.1016/j.biochi.2013.09.009. View

Takaesu G, Kishida S, Hiyama A, Yamaguchi K, Shibuya H, Irie K . TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway. Mol Cell. 2000; 5(4):649-58. DOI: 10.1016/s1097-2765(00)80244-0. View

Li Q, Cheng Z, Zhou L, Darmanis S, Neff N, Okamoto J . Developmental Heterogeneity of Microglia and Brain Myeloid Cells Revealed by Deep Single-Cell RNA Sequencing. Neuron. 2019; 101(2):207-223.e10. PMC: 6336504. DOI: 10.1016/j.neuron.2018.12.006. View

Lee J, Choi E, Kim Y, Kim Y, You H, Han Y . Statin exposure and the risk of dementia in individuals with hypercholesterolaemia. J Intern Med. 2020; 288(6):689-698. DOI: 10.1111/joim.13134. View

Chu L, Chen J, Wu P, Wu B . Atorvastatin prevents neuroinflammation in chronic constriction injury rats through nuclear NFκB downregulation in the dorsal root ganglion and spinal cord. ACS Chem Neurosci. 2015; 6(6):889-98. DOI: 10.1021/acschemneuro.5b00032. View

Lyons A, Murphy K, Clarke R, Lynch M . Atorvastatin prevents age-related and amyloid-β-induced microglial activation by blocking interferon-γ release from natural killer cells in the brain. J Neuroinflammation. 2011; 8:27. PMC: 3077319. DOI: 10.1186/1742-2094-8-27. View

10.

Bis J, Jian X, Kunkle B, Chen Y, Hamilton-Nelson K, Bush W . Whole exome sequencing study identifies novel rare and common Alzheimer's-Associated variants involved in immune response and transcriptional regulation. Mol Psychiatry. 2018; 25(8):1859-1875. PMC: 6375806. DOI: 10.1038/s41380-018-0112-7. View

11.

Farese Jr R, Walther T . Lipid droplets finally get a little R-E-S-P-E-C-T. Cell. 2009; 139(5):855-60. PMC: 3097139. DOI: 10.1016/j.cell.2009.11.005. View

12.

Olsen B, Schlesinger P, Baker N . Perturbations of membrane structure by cholesterol and cholesterol derivatives are determined by sterol orientation. J Am Chem Soc. 2009; 131(13):4854-65. PMC: 2675926. DOI: 10.1021/ja8095224. View

13.

Cohn W, Melnik M, Huang C, Teter B, Chandra S, Zhu C . Multi-Omics Analysis of Microglial Extracellular Vesicles From Human Alzheimer's Disease Brain Tissue Reveals Disease-Associated Signatures. Front Pharmacol. 2021; 12:766082. PMC: 8675946. DOI: 10.3389/fphar.2021.766082. View

14.

Dawson G . Measuring brain lipids. Biochim Biophys Acta. 2015; 1851(8):1026-39. PMC: 4457555. DOI: 10.1016/j.bbalip.2015.02.007. View

15.

Peri F, Nusslein-Volhard C . Live imaging of neuronal degradation by microglia reveals a role for v0-ATPase a1 in phagosomal fusion in vivo. Cell. 2008; 133(5):916-27. DOI: 10.1016/j.cell.2008.04.037. View

16.

Pascual-Garcia M, Rue L, Leon T, Julve J, Carbo J, Matalonga J . Reciprocal negative cross-talk between liver X receptors (LXRs) and STAT1: effects on IFN-γ-induced inflammatory responses and LXR-dependent gene expression. J Immunol. 2013; 190(12):6520-32. DOI: 10.4049/jimmunol.1201393. View

17.

Chang T, Yamauchi Y, Hasan M, Chang C . Cellular cholesterol homeostasis and Alzheimer's disease. J Lipid Res. 2017; 58(12):2239-2254. PMC: 5711498. DOI: 10.1194/jlr.R075630. View

18.

Wang S, Zhang X, Zhai L, Sheng X, Zheng W, Chu H . Atorvastatin Attenuates Cognitive Deficits and Neuroinflammation Induced by Aβ Involving Modulation of TLR4/TRAF6/NF-κB Pathway. J Mol Neurosci. 2018; 64(3):363-373. DOI: 10.1007/s12031-018-1032-3. View

19.

Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland T . A Unique Microglia Type Associated with Restricting Development of Alzheimer's Disease. Cell. 2017; 169(7):1276-1290.e17. DOI: 10.1016/j.cell.2017.05.018. View

20.

van der Most P, Dolga A, Nijholt I, Luiten P, Eisel U . Statins: mechanisms of neuroprotection. Prog Neurobiol. 2009; 88(1):64-75. DOI: 10.1016/j.pneurobio.2009.02.002. View